Medtronic plc (MDT) — Stock Price, Chart & Analysis
Medtronic plc (MDT) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $111.57B and a trailing P/E ratio of 23.06. Over the past 52 weeks, MDT has traded between $73.31 and $106.33. Medtronic plc pays a dividend yielding 3.4%. View the live MDT chart, technical opinion, analyst ratings, fundamentals and latest news below.
Medtronic plc (MDT) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $111.57B |
| P/E ratio (TTM) | 23.06 |
| EPS (TTM) | $3.78 |
| Dividend yield | 3.4% |
| 52-week high | $106.33 |
| 52-week low | $73.31 |
| Beta | 0.57 |
| Avg. volume | 9.53M |
| Sector | Healthcare |
| Industry | Medical Devices |
Frequently asked questions about Medtronic plc (MDT)
How much does one share of Medtronic plc cost?
As of the latest update, one share of Medtronic plc (MDT) trades at $100 (+0.00% today).
What is Medtronic plc's market cap?
Medtronic plc has a market capitalization of approximately $111.57B.
What is Medtronic plc's P/E ratio?
Medtronic plc has a trailing price-to-earnings (P/E) ratio of 23.06.
What is Medtronic plc's earnings per share (EPS)?
Medtronic plc's trailing twelve-month EPS is $3.78.
Does Medtronic plc pay a dividend?
Yes — Medtronic plc pays a dividend with a yield of 3.4% ($2.88 per share annually).
What is Medtronic plc's 52-week trading range?
Over the past year, MDT has traded between $73.31 and $106.33.
What is the analyst price target for Medtronic plc?
The mean analyst price target for Medtronic plc is $98.44. This is informational only and not investment advice.
Latest Medtronic plc (MDT) news
- Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular ArrhythmiasNews · Aug 8, 2026
- Medtronic gets CE mark for ablation to treat ventricular tachycardiaNews · Aug 7, 2026
- ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in FocusNews · Aug 6, 2026
- ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?News · Aug 6, 2026
- Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top EstimatesNews · Aug 6, 2026
- Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmiasNews · Aug 6, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live MDT dashboard…